Nancy J. Hutson - May 19, 2022 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc (PHASQ)

Role: Director
Signature: /s/ John P. Sharp, Attorney-in-fact
Stock symbol: PHASQ
Transactions as of: May 19, 2022
Transactions value $: $0
Form type: 4
Date filed: 5/20/2022, 04:45 PM
Previous filing: Nov 8, 2021
Next filing: Jun 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PHASQ	Non-employee Director Stock Option (right to buy)	Award	$0	+17.5K		$0.00	17.5K	May 19, 2022	Common Stock	17.5K	$0.84	Direct	F1
transaction	PHASQ	Restricted Stock Units	Award	$0	+3.75K		$0.00	3.75K	May 19, 2022	Common Stock	3.75K		Direct	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date.
F2	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock.
F3	The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date.